MENU
+Compare
AMFPF
Stock ticker: OTC
AS OF
Dec 16 closing price
Price
$26.00
Change
+$1.00 (+4.00%)
Capitalization
8.23B

AMFPF stock forecast, quote, news & analysis

AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
A.I.Advisor
a Summary for AMFPF with price predictions
Dec 20, 2024

AMFPF's Indicator enters downward trend

The Aroon Indicator for AMFPF entered a downward trend on December 20, 2024. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 78 similar instances where the Aroon Indicator formed such a pattern. In of the 78 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.

The Stochastic Oscillator has been in the overbought zone for 2 days. Expect a price pull-back in the near future.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on December 03, 2024. You may want to consider a long position or call options on AMFPF as a result. In of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for AMFPF just turned positive on December 04, 2024. Looking at past instances where AMFPF's MACD turned positive, the stock continued to rise in of 22 cases over the following month. The odds of a continued upward trend are .

AMFPF may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.666) is normal, around the industry mean (7.608). P/E Ratio (40.207) is within average values for comparable stocks, (28.511). AMFPF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (4.521). Dividend Yield (0.010) settles around the average of (0.032) among similar stocks. P/S Ratio (2.760) is also within normal values, averaging (33.632).

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. AMFPF’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AMFPF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 78, placing this stock worse than average.

A.I.Advisor
published Dividends

AMFPF paid dividends on May 26, 2021

Amplifon S.p.A. AMFPF Stock Dividends
А dividend of $0.22 per share was paid with a record date of May 26, 2021, and an ex-dividend date of May 24, 2021. Read more...
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are McKesson Corp (NYSE:MCK).

Industry description

Healthcare distribution market can be segmented into pharmaceutical product distribution services, medical device distribution services, and biopharmaceutical product distribution services. In addition to serving as intermediaries, many medical distributors also purchase and take legal ownership of pharmaceuticals and manage inventory and credit risk. According to a Deloitte report, pharmaceutical distributors’ core services of efficient product distribution, inventory management, financial risk management, and information-sharing generate $33 billion-$53 billion in value annually to the U.S. health care ecosystem. Some prominent players in the overall medical distribution industry include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc. and Patterson Companies, Inc.

Market Cap

The average market capitalization across the Medical Distributors Industry is 9.87B. The market cap for tickers in the group ranges from 494.39K to 70.55B. MCK holds the highest valuation in this group at 70.55B. The lowest valued company is SNYR at 494.39K.

High and low price notable news

The average weekly price growth across all stocks in the Medical Distributors Industry was 1%. For the same Industry, the average monthly price growth was 3%, and the average quarterly price growth was 147%. SHPMF experienced the highest price growth at 33%, while COSM experienced the biggest fall at -19%.

Volume

The average weekly volume growth across all stocks in the Medical Distributors Industry was 242%. For the same stocks of the Industry, the average monthly volume growth was 170% and the average quarterly volume growth was 21%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 57
P/E Growth Rating: 55
Price Growth Rating: 57
SMR Rating: 79
Profit Risk Rating: 78
Seasonality Score: 34 (-100 ... +100)
View a ticker or compare two or three
AMFPF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Industry MedicalDistributors

Profile
Fundamentals
Details
Industry
N/A
Address
Via Ripamonti, 133
Phone
+39 2574721
Employees
11265
Web
https://corporate.amplifon.com